Stephen Basso is Chief Financial Officer of Innoviva, Inc.. Currently has a direct ownership of 22,402 shares of INVA, which is worth approximately $402,787. The most recent transaction as insider was on Feb 24, 2025, when has been sold 10,569 shares (Common Stock) at a price of $18.08 per share, resulting in proceeds of $191,087. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.4K
73.14% 3M change
85.2% 12M change
Total Value Held $402,787

Stephen Basso Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 24 2025
BUY
Grant, award, or other acquisition
$191,087 $18.08 p/Share
10,569 Added 32.06%
22,402 Common Stock
Feb 20 2025
SELL
Payment of exercise price or tax liability
$19,985 $18.07 p/Share
1,106 Reduced 8.55%
11,833 Common Stock
Nov 15 2024
BUY
Grant, award, or other acquisition
-
843 Added 6.12%
12,939 Common Stock
Mar 05 2024
BUY
Grant, award, or other acquisition
$179,988 $14.88 p/Share
12,096 Added 50.0%
12,096 Common Stock

Also insider at

INZY
Inozyme Pharma, Inc. Healthcare
SB

Stephen Basso

Chief Financial Officer
Boston, MA

Track Institutional and Insider Activities on INVA

Follow Innoviva, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVA shares.

Notify only if

Insider Trading

Get notified when an Innoviva, Inc. insider buys or sells INVA shares.

Notify only if

News

Receive news related to Innoviva, Inc.

Track Activities on INVA